Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Lasa Supergenerics Ltd

NSE: LASA · BSE: 540702 · Pharmaceuticals & Biotechnology · 15 announcements

Share price
₹5.32
Market cap
₹26.65 Cr
Revenue (annual)
₹25.14 Cr
Net profit (annual)
₹-34.09 Cr
P/E (TTM)
-1.6×Sector 47.4×
Promoter holding
53.65%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

17:08 IST BSE
Other Announcement

Lasa Supergenerics Other Announcement

Lasa Supergenerics submitted its Annual Secretarial Compliance Report for the year ended March 31, 2026. The report details governance compliance and historical penalties paid for procedural delays.

21:09 IST BSE
Other Announcement

Lasa Supergenerics Other Announcement

Lasa Supergenerics Limited disclosed Related Party Transactions totaling 35.36 for the period ending March 2026. The report ensures regulatory compliance and transparency regarding promoter-related dealings.

Value
₹35.36 Cr
Execution
Quarter and year ended March 31, 2026
17:50 IST NSE
Other Announcement

Lasa Supergenerics Other Announcement

Lasa Supergenerics Limited submitted its SDD Compliance Certificate for the quarter ended March 31, 2026. The company confirmed the maintenance of a Structured Digital Database in compliance with SEBI PIT Regulations, reporting two required events during the period with no non-compliances observed.